Back to results
US 2024/0002936 A1Published application
Use of brain organoids and single cell genomics to understand and treat neurodevelopmental and neuropsychiatric disorders
AssigneesPresident and Fellows of Harvard College, The Broad Institute, Inc., Massachusetts Institute of Technology
InventorsPaola Arlotta, Joshua Z. Levin, Amanda J. Kedaigle, Aviv Regev, Bruna Da Silveira Paulsen, Silvia Velasco, Martina Pigoni
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to methods of screening for pathological mechanisms in neurodevelopmental and neuropsychological disorders using brain organoids. The present disclosure is also directed to methods of screening agents using the brain organoids.
Claims20
A method of screening for pathological mechanisms in neurodevelopmental disorders comprising
- a. introducing one or more genetic variations to an organoid;
- and
- b. profiling the mutant organoids using single-cell RNA sequencing, thereby identifying phenotypic alterations as a result of the genetic variation.
A method of screening a therapeutic agent, the method comprising:
- a. contacting an organoid having one or more genetic variations with one or more candidate agents;
- and
- b. testing effects of the one or more candidate agents on asynchronous development of a cortical neuronal lineage.
Dependencies are inferred from the claim text.